{"name":"Bioxodes S.A.","slug":"bioxodes-s-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Ir-CPI","genericName":"Ir-CPI","slug":"ir-cpi","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Ir-CPI","genericName":"Ir-CPI","slug":"ir-cpi","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxOWXdaWnhJS1VVWWxkVWVMUWJBYjZVZWxIR2V1b1BXUi1YNjRvVkFBekdfZElxY2xXT0d6cXd1bF9mbzdRVllDZ1EzNU0zQldlb0V2Tmdjckx5UXRxNFhlM1BFdlg3YkE0LW1RQnVvWWdYQm44QXluSjY1WENZWEN2RkY1WVhsdl9WVFFxS2xCY0tyNGE1dkF5RW91T0ROR0ZFeHRCMFpwczZwTTdBT2dxaWw3TUhoMFF2Tm84U1VJa0F1d0tCZmlvY3BkZVVqSnNQVkJaZEpwdDh5N1V5Smp6aUNSZXlpNENHbS1GWmZtSlh6OUVQdzZPRV9WWjBIbExZWGtiRG9yUG5ZQQ?oc=5","date":"2025-10-07","type":"pipeline","source":"BioSpace","summary":"Bioxodes appoints industry veteran Philippe Monteyne as chairman as it accelerates late-stage development of breakthrough stroke candidate - BioSpace","headline":"Bioxodes appoints industry veteran Philippe Monteyne as chairman as it accelerates late-stage development of breakthroug","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}